Stockscreener 앱 받기
54.44
2.14%
-1.19
시간 외 거래:
54.40
-0.04
-0.07%
Gsk Plc Adr 주식(GSK)의 최신 뉴스
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim - GlobeNewswire Inc.
GSK out-licenses rights for rare liver disease drug to Alfasigma - MSN
GSK Fundamental Analysis & Valuation | Fair Value & Financial Strength | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill
Farther Finance Advisors LLC Grows Stock Position in GSK PLC Sponsored ADR $GSK - MarketBeat
GSK PLC Sponsored ADR $GSK Shares Sold by Miller Howard Investments Inc. NY - MarketBeat
GSK plc (ADR) stock (GB0009252882): Why Google Discover changes matter more now - AD HOC NEWS
GSK PLC Stock Operating Data - GuruFocus
GSK Forecast, Price Target & Analyst Ratings | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill
GSK PLC Sponsored ADR (NYSE:GSK) Sees Significant Growth in Short Interest - MarketBeat
GSK plc (ADR) stock (GB0009252882): Why its vaccines and specialty medicines strategy is suddenly wo - AD HOC NEWS
GSK Stock Chart | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill
GSK PLC Sponsored ADR $GSK Shares Acquired by Prime Capital Investment Advisors LLC - MarketBeat
Douglas Lane & Associates LLC Cuts Holdings in GSK PLC Sponsored ADR $GSK - MarketBeat
GSK plc (GSK) stock price, news, quote and history - Yahoo Finance Singapore
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo! Finance Canada
GSK plc (ADR) Stock: ViiV Healthcare Ownership Restructured as Pfizer Exits, Strengthening GSK's HIV - AD HOC NEWS
GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Recommendation of "Reduce" from Analysts - MarketBeat
GSK Stock Price, Quote & Chart | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill
GSK plc (ADR) stock surges on FDA approval for Lynavoy as pipeline momentum builds for 2026 - AD HOC NEWS
GSK's Q4 earnings & sales beat estimates, stock up on '26 outlook - MSN
GSK PLC Sponsored ADR (NYSE:GSK) Short Interest Update - MarketBeat
FDA Broadens Access To GSK's Respiratory Syncytial Virus Shot For Younger High-Risk Adults - Sahm
GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma - Finviz
GSK PLC Sponsored ADR $GSK Shares Sold by Quantbot Technologies LP - MarketBeat
GSK (NYSE: GSK) files 2025 Form 20-F with audited 2025 financial statements - Stock Titan
Price Over Earnings Overview: GSK - Sahm
GlaxoSmithKline Pharma: Can India’s GSK Arm Still Reward US Investors? - AD HOC NEWS
GSK PLC Sponsored ADR $GSK Shares Sold by Kahn Brothers Group Inc. - MarketBeat
GSK PLC Sponsored ADR (NYSE:GSK) Short Interest Down 26.3% in February - MarketBeat
CapEx per share of GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs – BCBA:GSKD - TradingView
Fisher Asset Management LLC Purchases 889,210 Shares of GSK PLC Sponsored ADR $GSK - MarketBeat
Antibiotics Market - GlobeNewswire Inc.
GSK Expands Pipeline With $950 Million Pulmonary Hypertension Power Play - Sahm
SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus - Finviz
GSK (GSK) Announces 75.6% Vaccine Effectiveness for Arexvy in Real-World RSV Study - Finviz
1.24%
2.42%
자본화:
|
볼륨(24시간):